Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P.

Int J Cancer. 2005 Feb 20;113(5):819-24.

2.

Plasma vitamin B12 concentrations and the risk of colorectal cancer: a nested case-referent study.

Dahlin AM, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R.

Int J Cancer. 2008 May 1;122(9):2057-61.

3.

Serum folate and vitamin B12 concentrations in relation to prostate cancer risk--a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort.

de Vogel S, Meyer K, Fredriksen Å, Ulvik A, Ueland PM, Nygård O, Vollset SE, Tell GS, Tretli S, Bjørge T.

Int J Epidemiol. 2013 Feb;42(1):201-10. doi: 10.1093/ije/dys199.

PMID:
23508410
4.

Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.

Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, Chen L, Harris R, Davis M, Marsden G, Johnston C, Lane JA, Ebbing M, Bønaa KH, Nygård O, Ueland PM, Grau MV, Baron JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1632-42. doi: 10.1158/1055-9965.EPI-10-0180. Epub 2010 May 25. Review.

5.

Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake.

Van Guelpen B, Hultdin J, Johansson I, Stegmayr B, Hallmans G, Nilsson TK, Weinehall L, Witthöft C, Palmqvist R, Winkvist A.

Stroke. 2005 Jul;36(7):1426-31. Epub 2005 Jun 2.

6.

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.

Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2003 Mar 5;95(5):373-80.

PMID:
12618502
7.

Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.

Schernhammer E, Wolpin B, Rifai N, Cochrane B, Manson JA, Ma J, Giovannucci E, Thomson C, Stampfer MJ, Fuchs C.

Cancer Res. 2007 Jun 1;67(11):5553-60.

8.

Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.

Van Guelpen B, Hultdin J, Johansson I, Witthöft C, Weinehall L, Eliasson M, Hallmans G, Palmqvist R, Jansson JH, Winkvist A.

J Intern Med. 2009 Aug;266(2):182-95. doi: 10.1111/j.1365-2796.2009.02077.x. Epub 2009 Feb 27.

9.
10.

Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study.

Van Guelpen BR, Wirén SM, Bergh AR, Hallmans G, Stattin PE, Hultdin J.

Eur J Cancer Prev. 2006 Feb;15(1):46-50.

PMID:
16374229
11.

Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.

Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC.

Am J Epidemiol. 1996 May 1;143(9):845-59.

PMID:
8610698
13.

Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekin D, Erturk K, Bozbey HU, Olmuscelik O, Kiziltan H, Tuna S, Tas F.

Exp Oncol. 2015 Sep;37(3):218-22.

PMID:
26422108
14.

Folate and B12 in prostate cancer.

Collin SM.

Adv Clin Chem. 2013;60:1-63. Review.

PMID:
23724740
15.

Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study.

Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, Tell GS.

J Bone Miner Res. 2007 May;22(5):747-56.

16.

Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.

Johansson M, Appleby PN, Allen NE, Travis RC, Roddam AW, Egevad L, Jenab M, Rinaldi S, Kiemeney LA, Bueno-de-Mesquita HB, Vollset SE, Ueland PM, Sánchez MJ, Quirós JR, González CA, Larrañaga N, Chirlaque MD, Ardanaz E, Sieri S, Palli D, Vineis P, Tumino R, Linseisen J, Kaaks R, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Khaw KT, Bingham S, Hallmans G, Riboli E, Stattin P, Key TJ.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):279-85. doi: 10.1158/1055-9965.EPI-07-0657.

17.

Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration.

Lee BJ, Lin PT, Liaw YP, Chang SJ, Cheng CH, Huang YC.

Nutrition. 2003 Jul-Aug;19(7-8):577-83.

PMID:
12831941
18.

The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine.

Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock GW, Helzlsouer KJ.

Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):761-4.

19.

Folate, vitamin B12, homocysteine, and depressive symptoms in a population sample of older Chinese adults.

Ng TP, Feng L, Niti M, Kua EH, Yap KB.

J Am Geriatr Soc. 2009 May;57(5):871-6.

PMID:
19484842
20.

Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men.

Fenech MF, Dreosti IE, Rinaldi JR.

Carcinogenesis. 1997 Jul;18(7):1329-36.

PMID:
9230275

Supplemental Content

Support Center